CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis
Crossref DOI link: https://doi.org/10.1007/s10557-016-6705-y
Published Online: 2016-12-07
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jiang, Minghuan
You, Joyce H. S.
Funding for this research was provided by:
None
License valid from 2016-12-07